Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma
Clinical trial NCT00483509 · COMPLETED
Trial details
- NCT number
- NCT00483509
- Sponsor
- AGC Biologics S.p.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-14
- Primary completion
- 2010-09-22
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.